Pharma Co. Signs License Agreement With Boston Medical Center
Research Report
FDA Expedites Review of Gene Therapy Co.'s Drug
This article is issued on behalf of Treatment.com AI Inc. Is This Centrally Positioned AI Healthcare Co. Set to Transform the Industry?
Contributed Opinion 
Technical Analyst Clive Maund explains why he thinks Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) offers potential upside to investors.
Medical Equipment Co. Shows Strong Profit Margin
Research Report
Biopharma Using AI to Find Promising Cancer Drug Candidates
New Data Supports BLA Package
Research Report
New Quebec Law Affecting Healthcare Co.'s Bottom Line
Research Report
Biotech's Parkinson's Drug Could Be Worth US$4B, Analyst Says
Clinical-stage biotechnology company Gain Therapeutics Inc.'s (GANX:NASDAQ) drug treating Parkinson's disease could be a "US$4 billion drug," according to one analyst who recently initiated coverage on the Maryland company.California Biopharma Shows Promising Phase 1 Data
Research Report
Artelo Biosciences Inc. (ARTL:NASDAQ) recently reported promising Phase 1 results from its CAReS trial evaluating ART27.13 for cancer-related anorexia, according to a D. Boral Capital research note. Drug Trial Shows Positive Interim Results for ALS Treatment
Biopharmaceutical company MediciNova Inc. (MNOV:NASDAQ) announced the release of a positive interim analysis of its treatment of Amyotrophic Lateral Sclerosis (ALS). Find out why one analyst says the drug has "potential" to treat the disease and maybe others.FDA Decision on Drug for Bone Marrow Due Early 2025
Research Report
The manufacturer sheds light on the amount and remittance schedule of the cash payment it must remit to its partner if the drug gets approved, noted a Leede Financial Inc. report. Is This California Biopharma Co. In the Right Place at the Right Time?
Research Report
Roth MKM analyst Dr. Jonathan Aschoff highlighted GT Biopharma Inc.'s (GTBP:NASDAQ) development of unique precision therapeutic agents using camelid-derived nanobodies. Regenerative Medicine Co. Adds Saudi Arabia Diabetes Initiative
Leading regenerative medicine company Sernova Corp. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) announces agreement to explore fighting type I diabetes in Saudi Arabia. Read why one analyst believes the company's technology is "advanced."Approval Sought in Japan for New Drug to Lower Cholesterol
Research Report
The U.S. biopharma behind the drug is "pushing for accelerated adoption and expansion into additional territories," noted an H.C. Wainwright & Co. report. AI Accelerates Breakthroughs in Cancer Drug Discovery
Rakovina Therapeutics Inc. (RKV:TSX.V) is advancing cancer drug discovery with its Deep Docking AI platform. Read more about their recent developments and future plans.Intratubal Insemination Device Shown Effective, Safe
Research Report
Pregnancy rates with this "only new innovation for infertility in decades" were "impressive" in a pivotal study in women with male factor infertility, noted an H.C. Wainwright & Co. report. 
Streetwise Key Charts
